In 2023, Michael Rossi earned $1.08M in total compensation at Y-mAbs Therapeutics, Inc., including $705.60K salary and $71.62K bonus. Most recently acquired 105,300 shares in Jan 2025. Currently holds stock worth $6.31M. 2+ years at the helm of Y-mAbs Therapeutics, Inc..
Compensation History
Annual executive compensation data for Michael Rossi, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.08M
Salary
$705.60K
Bonus
$71.62K
Other
$300.00K
Salary
$705.60KBoard Justification
Our compensation philosophy is designed to attract, retain, and motivate superior executive talent, providing incentives that reward the achievement of performance goals that directly correlate to the enhancement of stockholder value.
Bonus
$71.62KBoard Justification
Mr. Rossi's cash incentive bonus for 2023 was paid at the target amount and prorated based on days worked within the year, conditioned on continuous employment with the Company through December 31, 2023.
Other Compensation
$300.00KBoard Justification
Mr. Rossi received a sign-on bonus of $300,000, which was earned and paid in November 2023.
Restricted Stock
Board Justification
No stock was vested in 2023 as Mr. Rossi joined the Company in November 2023 and no stock grants were made prior to that.
Performance Metrics
The performance metrics for Mr. Rossi's compensation were based on the achievement of corporate performance objectives for 2023.
Michael Rossi
CEO of Y-mAbs Therapeutics, Inc.
Education
Bachelor of Science in Pharmacy
Sector of Economy
Healthcare
Born
January 1, 1972 - 53 years ago
CEO of Y-mAbs Therapeutics, Inc. for
2 years 1 month (Nov 2023 - Present)
Previous Experience
Most recently served as Medical Group President of Mirion Technologies, Inc., and has over 30 years of experience in the radiopharmaceutical industry.
Other Y-mAbs Therapeutics, Inc. CEOs
Holdings
Track Michael Rossi's stock holdings and portfolio value over time.
Insider Trading
Michael Rossi's recent stock transactions, purchases, and sales filed with the SEC.
105,300 shares
YMAB
Jan 17, 2025
Received
35,700 shares
YMAB
Feb 12, 2024
Received
41,242 shares
MIR
Mar 29, 2023
Received
$76.14K
CWT at $25.17/share
Mar 1, 2016
Received
$77.69K
CWT at $34.87/share
Mar 1, 2011
Purchase
Rivals
Compare Michael Rossi with competitor CEOs and industry peers.